Kraig Biocraft Laboratories (KBLB) Cash from Investing Activities (2016 - 2021)
Kraig Biocraft Laboratories (KBLB) has disclosed Cash from Investing Activities for 8 consecutive years, with -$17233.0 as the latest value for Q4 2021.
- Quarterly Cash from Investing Activities changed N/A to -$17233.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$547370.0 through Dec 2021, changed N/A year-over-year, with the annual reading at $438042.0 for FY2025, 10431.18% up from the prior year.
- Cash from Investing Activities hit -$17233.0 in Q4 2021 for Kraig Biocraft Laboratories, up from -$525017.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$1304.0 in Q2 2018 to a low of -$525017.0 in Q3 2021.
- Historically, Cash from Investing Activities has averaged -$58998.5 across 3 years, with a median of -$5687.5 in 2018.
- Biggest YoY gain for Cash from Investing Activities was 92.67% in 2018; the steepest drop was 350.97% in 2018.
- Year by year, Cash from Investing Activities stood at -$6997.0 in 2017, then soared by 44.42% to -$3889.0 in 2018, then crashed by 343.12% to -$17233.0 in 2021.
- Business Quant data shows Cash from Investing Activities for KBLB at -$17233.0 in Q4 2021, -$525017.0 in Q3 2021, and -$5120.0 in Q2 2021.